Clinical Trial Update: Effect of Intravenous Methylprednisolone and Intravenous Erythropoietin in Toxic Optic Neuropathies: Randomized Clinical Trial. [Phase 2, Phase 3]

View source ↗

Summary

A randomized clinical trial evaluating intravenous methylprednisolone and intravenous erythropoietin for toxic optic neuropathies; phases include Phase 2 and Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Toxic Optic Neuropathy

Drugs mentioned

• Erythropoietin (erythropoietin)
• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Toxic Optic Neuropathy, Treatment | Phase 2, Phase 3 | Status: UNKNOWN